<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors describe course and outcome of eight patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> as the first thrombotic manifestation of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> who received low-dose aspirin as prophylactic treatment </plain></SENT>
<SENT sid="1" pm="."><plain>During 8.9 years of follow-up, two patients had a recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> rate per 100 patient-years on aspirin was 3.5 (95% CI 0.4 to 12.5) </plain></SENT>
</text></document>